Future Medicine Co., Ltd. (XKON:341170)
South Korea · Delayed Price · Currency is KRW 781.00
-137.00 (-14.92%)
At close: May 29, 2026
Future Medicine Market Cap
Future Medicine has a market cap or net worth of 7.05 billion as of May 29, 2026. Its market cap has decreased by -52.52% in one year.
Market Cap
7.05B
Enterprise Value
n/a
Revenue
1.00B
Ranking
n/a
PE Ratio
n/a
Stock Price
781.00
Market Cap Chart
Since July 27, 2022, Future Medicine's market cap has decreased from 89.97B to 7.05B, a decrease of -92.17%. That is a compound annual growth rate of -48.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 7.05B | -75.49% |
| Dec 30, 2025 | 28.75B | 144.48% |
| Dec 30, 2024 | 11.76B | -81.54% |
| Dec 28, 2023 | 63.72B | 34.97% |
| Dec 29, 2022 | 47.21B | -47.53% |
| Jul 27, 2022 | 89.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seoul Pharma | 28.04B |
| Pharmsville | 27.55B |
| Daesung Microbiological Labs. | 25.23B |
| ChoA Pharmaceutical Co., LTD. | 22.58B |
| BIFIDO | 22.41B |
| Hurum | 20.48B |
| Union Korea Pharm | 19.70B |
| Kwangdong Healthbio | 17.56B |